Injection technique optimization can reduce local site reactions
These findings have expanded how doctors think about using these medications
See source Starting at a low GLP-1 dose isn't just common, it's clinical best practice
,
Rather, the profitability for both PBMs and the plan sponsors lies in the rebates. 4 Over the past few years, there have been various attempts to hold PBMs accountable for unfair practices, such as spread pricing
Figure 1 Discussion In the presented case of a newly diagnosed patient with type 2 diabetes, euDKA occurred at the very early onset after initiation of combined therapy with GLP-1RA and SGLT2i, in the absence of infection or other precipitating factors (such as alcohol overdose, pancreatitis, pregnancy), and proved refractory to standard therapy with insulin, glucose, and fluid resuscitation